Target intelligence / Profile preview

Novel transcript, sense overlapping ATXN10 (ENSG00000280383)

Target: ENSG00000280383
Molecular classification: Long non-coding RNA (lncRNA)

Overview

ENSG00000280383 encodes a long non-coding RNA classified as "novel transcript, sense overlapping ATXN10."[2] It does not encode a protein, and there is currently no evidence linking this transcript directly to biological functions, disease processes, or drug targeting. No canonical protein, receptor, or enzyme matches this entry. No alternative names, disease associations, or therapeutic relevance are reported in major databases. This locus is best described as a genomic annotation for a non-coding RNA overlapping the ATXN10 gene region, and it is not considered a current therapeutic target[2].

Mechanism of action

Not established

Biological functions

Unknown

Beyond the preview

Go deeper on Novel transcript, sense overlapping ATXN10 (ENSG00000280383).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense overlapping ATXN10 (ENSG00000280383).

Explore the full profile